Meeting the challenges of bioanalytical outsourcing: understanding the hidden cost of price pressure


“The keys to a successful manufacturing model include ensuring the retention of experienced scientists, investing in advanced training for all scientists and thoughtful operation processes.” Historically, it is important for any company to continually reduce the cost of developing their products. These pressures exist in both small start-up pharmaceutical companies, as well as the largest companies. These efforts include reducing outsourcing costs for drug development. The focus of this editorial is to describe the impact this pressure is having on the relationship between pharmaceutical companies and the bioanalytical CROs that support them. There are several primary relationship models that pharmaceutical...

To view this content, please register now for access

It's completely free